SCHEMBL3540104

SCHEMBL3540104

CCOC(=O)C(=O)CC(=O)c1cc(F)cc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
POLB P06746 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPT P10636 5/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
GAA P10253 1/20 0.42
CHRM1 P11229 2/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
TSHR P16473 1/20 0.38
CASP3 P42574 1/20 0.38
TRPV1 Q8NER1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1765258 0.86 GPR35 (0.46) ALDH1A1POLBSMN1; SMN2GPR35
SCHEMBL3408623 0.85 ALDH1A1 (0.51) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL212542 0.84 SMN1; SMN2 (0.54) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL1739390 0.83 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL2459005 0.83 MEN1 (0.59) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL25903815 0.82 ALDH1A1 (0.41) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL21440338 0.82 ALDH1A1 (0.41) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL29706857 0.82 ALDH1A1 (0.41) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL17895465 0.80 ALDH1A1 (0.59) ALDH1A1POLBSMN1; SMN2MAPTMEN1
SCHEMBL2529911 0.79 CES2 (0.56) ALDH1A1POLBSMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US disclosed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US disclosed
EP-1935881-A1 ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds OPRL1, NPSR1, NPBWR1 ALDH1A1 1623/4885POLB 4463/4885SMN1; SMN2 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.